Skip to main content
Clinical Trials/NCT01854411
NCT01854411CompletedNot Applicable

Ibuprofen and Ketoprofen Concentrations in Human Mature Milk. PK Study in Breastmilk AOR-10127 "Antalait" Study

Assistance Publique - Hôpitaux de Paris1 site in 1 country35 target enrollmentStarted: September 1, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
35
Locations
1
Primary Endpoint
concentration of ketoprofene in human mature milk

Study Overview

Brief Summary

The purpose of this study is to determine whether ibuprofen and ketoprofen do not enter into mature breastmilk that could allowed breastfeeding during a long time

Detailed Description

Analgesics are frequently used to prevent and treat pain and inflammatory disease.

Due to a lack of information on drug's human milk transfer, breastfeeding is sometimes contraindicated. Mothers are advised to either stop breastfeeding or if they don't, not to treat themselves. Since the fatal neonatal case with codeine during breastfeeding, analgesics are being reviewed. Ibuprofen seems to have the best benefit-risk ratio during the post-partum period. However there are no pharmacologic data about the use of ibuprofen during breastfeeding, after the colostrum phase.

This study aims to determine the relative infant dose (RID) of ibuprofen in human mature milk. Considering the increased interest in NSAIDs in light of the codeine case, this is an important information. It will help health practitioners when advising and treating breastfeeding women.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 49 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •breastfeeding women after the first week of delivery
  • •breastfeeding women treated by ketoprofen or ibuprofen per os more than 24 hours
  • •Written Informed Consent

Exclusion Criteria

  • •breastfeeding women treated by naproxene
  • •Curator or justice decision's

Arms & Interventions

analgesic dose measure

breastfeeding mother who will take analgesics

Intervention: analgesic measure (Other)

Outcomes

Primary Outcomes

concentration of ketoprofene in human mature milk

Time Frame: 6 months

concentration of ibuprofene in human mature milk.

Time Frame: 6 months

Secondary Outcomes

  • comparison between ibuprofene and ketoprofene concentrations in the human breastmilk(6 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials